Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human subjects. Compliance with GCP ensures that the rights, safety, and well-being of trial participants are protected and that clinical trial data are credible and accurate.
What Is GCP?
GCP is a set of internationally recognized standards developed by the International Council for Harmonisation (ICH) that provides a unified framework for clinical research. The cornerstone of GCP is the ICH E6 guideline, which outlines the responsibilities of sponsors, investigators, and ethics committees throughout the clinical trial lifecycle. Adherence to GCP is a regulatory requirement in most countries and is essential for gaining marketing authorization for new medicinal products.
Regulatory Framework
GCP is underpinned by several major regulatory frameworks, including ICH E6(R2) and the recently updated ICH E6(R3) guideline. In the United States, the Code of Federal Regulations (21 CFR Parts 50, 56, and 312) governs clinical trials, while the EU Clinical Trials Regulation (EU CTR 536/2014) provides the legal basis in Europe. These regulations collectively define the standards for trial conduct, participant protection, and data integrity.
Key Requirements
The key requirements of GCP include obtaining informed consent from all participants, securing ethics committee approval before trial initiation, and ensuring proper trial oversight by qualified investigators and sponsors. GCP also mandates meticulous source data verification, adverse event reporting, and record-keeping to allow for accurate reconstruction and evaluation of the trial. Investigators and their teams must be appropriately qualified and trained in GCP principles.
Documentation
GCP demands comprehensive documentation at every stage of a clinical trial. The Trial Master File (TMF) serves as the central repository for essential documents as outlined in the ICH E6 Section 8, including the protocol, investigator’s brochure, case report forms, and regulatory approvals. All clinical records must be attributable, legible, contemporaneous, original, and accurate (ALCOA) to support data integrity and regulatory inspection readiness.
Conclusion
GCP provides the ethical and scientific foundation for clinical research involving human subjects. Regulatory compliance with ICH E6 and applicable national regulations is mandatory for marketing authorization and ensures participant safety. A thorough understanding of GCP principles is essential for all professionals involved in clinical trial conduct.
